Biology + Radiation & Cancer Physics Science Highlights

This session highlights ten of the most clinically relevant abstracts within the Biology + Radiation & Cancer Physics track(s) of the 2022 ASTRO Annual Meeting Scientific Program. These noteworthy scientific abstracts share important findings and feature cutting edge research from leaders in the field. The Discussant compares and contrasts the current data to help you digest the latest science; places the study into context; and describes how the study can be put into clinical practice, if recommended. 
 
Highlighted Abstracts include – 

Biology

  • Caloric Restriction Decreases Radiation Induced Normal Tissue Toxicity
  • Intratumoral dsRNA Sensor Activation Redirects Radiation-Associated Myeloid Cells to Ignite Local and Systemic Anti-tumor Immunity in Undifferentiated Pleomorphic Sarcoma
  • Phagocytosis Checkpoint Blockade Overcomes Immunosuppression Triggered by Radiation Therapy and PD1 Inhibition
  • Discovery of a Novel Driver of Radioresistance in Pancreatic Cancer (PC) Using Genome-wide RNA-seq
  • Long Term Outcomes and Genetic Predictors of Response to Metastasis Directed Therapy Versus Observation in Oligometastatic Castration-Sensitive Prostate Cancer: A Pooled Analysis of the STOMP and ORIOLE Trials

Radiation & Cancer Physics

  • Correlation of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events and Feasibility of Coronary Artery Sparing Treatment Planning in Lung Cancer
  • Pulmonary Function Test Results for Patients Treated on a Two-Institution, 4DCT-Ventilation Functional Avoidance Prospective Clinical Trial
  • Prospective Assessment of Diffusion-Weighted-MRI as a Biomarker of Treatment Response 
    and Disease Control in Head and Neck Cancer
  • Daily Assessment of On-Treatment Tumor Regression by Cone Beam CT as a Prognostic Dynamic Biomarker in Nasopharyngeal Cancer
  • Prospective clinical integration of AI based treatment planning tool for whole breast radiation therapy (WBRT): A single institution’s three-year experienc

This activity is available from June 27, 2023, through 11:59 p.m. Eastern time on December 31, 2023. 

This activity was originally recorded at ASTRO’s 2022 Annual Meeting.

Target Audience

The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, physicists and radiation dosimetrists. 

 

Learning Objectives

Upon completion of this activity, participants:

  • Have had the opportunity to increase their level of knowledge, as required to improve competency and performance in the field of oncology.
  • When appropriate, implement the advances in radiation oncology that help improve patient outcomes and quality of life. 
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.50 Certificate of Attendance
    This activity was designated for 0.50 AMA PRA Category 1 Credit™.
Course opens: 
06/27/2023
Course expires: 
12/31/2023
Cost:
$79.00
Rating: 
0

Biology Discussant: Randall J. Kimple, MD, PhD, FASTRO, University of Wisconsin School of Medicine and Public Health 

  • Funding from NIH, RSNA, ASCO, Bridge Bio
  • Consultant or Fees from Galera Therapeutics, MELE Associates, Guidepoint Global 

Radiation & Cancer Physics Discussant: James Balter, PhD, FASTRO, University of Michigan 

  • No conflicts of interest to disclose 

The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.

Disclosure link: 
Committee Disclosures

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.50 Certificate of Attendance
    This activity was designated for 0.50 AMA PRA Category 1 Credit™.

Price

Cost:
$79.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the free member rate.

Nonmember: $79
Member: Free 

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website until December 31, 2023, regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.